13F reference period
Q2 2026
Security Snapshot
Turn Therapeutics Inc. - COM (TTRX) Institutional Ownership
CUSIP: 90021W105
13F Institutional Holders and Ownership History from Q4 2025 to Q3 2026
Institutions Reporting
29
Shares (Excl. Options)
1,156,539
Price
$7.30
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM
- Symbol
- TTRX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,156,539
- Total 13F value
- $8,484,593
- Portfolio coverage rank
- 0%
- Share change
- +694,229
- Value change
- +$5,231,610
- Number of holders
- 29
- SEC-reported price per share
- $14.39
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- TTRX - Turn Therapeutics Inc. - COM is tracked under CUSIP 90021W105.
- 29 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 20 to 29 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,479,391 to $8,484,593.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 29 institutions filings for Q2 2026.
Security key
90021W105
13F reference period
Q2 2026
13F holders
29
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
TTRX full holder history
Turn Therapeutics Inc. SEC filings
Turn Therapeutics Inc. company facts
Turn Therapeutics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 90021W105:
As of 30 Jun 2026, 29 institutional investors reported holding 1,156,539 shares of Turn Therapeutics Inc. - COM (TTRX).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Headline period
Q2 2026
Rows shown
1-4 of 4